ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Abstract: PO0782

Identification of Kidney Disease Diagnoses in Patients with Diabetes by Biopsies and Electronic Health Records

Session Information

Category: Diabetic Kidney Disease

  • 602 Diabetic Kidney Disease: Clinical

Authors

  • Fast, Eva, Goldfinch Bio Inc, Cambridge, Massachusetts, United States
  • Jones, Cami R., Providence Washington, Spokane, Washington, United States
  • Daratha, Kenn B., Providence Washington, Spokane, Washington, United States
  • Nicholas, Susanne B., University of California Los Angeles David Geffen School of Medicine, Los Angeles, California, United States
  • Alicic, Radica Z., Providence Washington, Spokane, Washington, United States
  • Nast, Cynthia C., Cedars-Sinai Medical Center, Los Angeles, California, United States
  • Zuckerman, Jonathan E., University of California Los Angeles David Geffen School of Medicine, Los Angeles, California, United States
  • Patel, Sarthak, Goldfinch Bio Inc, Cambridge, Massachusetts, United States
  • Tebbe, Adam, Goldfinch Bio Inc, Cambridge, Massachusetts, United States
  • Penny, Michelle, Goldfinch Bio Inc, Cambridge, Massachusetts, United States
  • Norris, Keith C., University of California Los Angeles David Geffen School of Medicine, Los Angeles, California, United States
  • Tuttle, Katherine R., Providence Washington, Spokane, Washington, United States
Background

Diabetic kidney disease (DKD) refers to chronic kidney disease in diabetes, but not a specific diagnosis. This report describes a patient cohort with electronic health record (EHR) data linked to manual data abstraction for kidney histopathology.

Methods

Patients were selected from the Center for Kidney Disease Research, Education, and Hope (CURE-CKD) registry which contains curated EHR clinical and administrative data from two large healthcare systems. Inclusion criteria consisted of a native kidney biopsy, diagnoses of diabetes and CKD but not on dialysis. Clinical investigators manually abstracted health history, laboratory data, and histological features from kidney biopsy reports. DKD was classified as: diabetic nephropathy (DN), DN mixed with nondiabetic lesions (Mixed), and nondiabetic lesions only (Other).

Results

In 523 patients with diabetes who underwent kidney biopsy in the years 2015-2017 (Table), diagnostic frequencies were DN 39.8% (n=208), Mixed 36.9% (n=193), Other 23.3% (n=122). Patients with DN were younger, displayed higher albuminuria, increased nodular glomerulosclerosis and arteriolar hyalinosis than the Mixed group. Those with DN more commonly had diabetes duration >10 years and higher albuminuria compared to the Other group, while lesions characteristic of DN (mesangial expansion, nodular glomerulosclerosis, GBM thickening, arteriolar hyalinosis, tubular basement membrane thickening) were uncommon in Other.

Conclusion

Higher levels of albuminuria, nodular glomerulosclerosis and arteriolar hyalinosis were distinctly more common in DN compared to Mixed and Other groups, and nodular glomerulosclerosis was rarely observed in the Other group. Future work will use machine learning models of the EHR data to predict DN and select precision therapies.

Funding

  • Commercial Support